Pegpleranib sodium is a polyethylene glycol-modified nucleic acid aptamer that specifically binds to the homodimers and heterodimers of PDGF-BB and PDGF-AB, thereby inhibiting their interaction with associated tyrosine kinase receptors.
Target:
PDGFR
* VAT and and shipping costs not included. Errors and price changes excepted
